An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome

• Main Authors: Wagner, A., Kellow, J., Lee, O.Y., Chang, F.Y., Thongsawat, S., Mazlam, M.Z., Yuen, H., Gwee, K.A., Bak, Y.T., Jones, J.
• Other Authors: MEDICINE
• Format: Article
• Published: 2014
• Online Access: http://scholarbank.nus.edu.sg/handle/10635/117556
• Institution: National University of Singapore

10.1136/gut.52.5.671